Form 8-K - Current report:
SEC Accession No. 0001193125-25-023130
Filing Date
2025-02-10
Accepted
2025-02-10 07:01:01
Documents
15
Period of Report
2025-02-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d931376d8k.htm   iXBRL 8-K 25330
2 EX-99.1 d931376dex991.htm EX-99.1 8298
6 GRAPHIC g931376g0208072810828.jpg GRAPHIC 2257
  Complete submission text file 0001193125-25-023130.txt   158519

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plrx-20250207.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20250207_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20250207_pre.xml EX-101.PRE 10814
17 EXTRACTED XBRL INSTANCE DOCUMENT d931376d8k_htm.xml XML 3517
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 25603616
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)